U.S. Physical Therapy - USPH Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" USPH shares.
View USPH analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued twelve-month price objectives for U.S. Physical Therapy's shares. Their USPH share price forecasts range from $110.00 to $110.00. On average, they expect the company's share price to reach $110.00 in the next year. This suggests a possible upside of 19.6% from the stock's current price.
View analysts price targets for USPH or view top-rated stocks among Wall Street analysts.

U.S. Physical Therapy's stock was trading at $81.03 at the beginning of the year. Since then, USPH stock has increased by 13.5% and is now trading at $91.95.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our USPH earnings forecast.

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Thursday, November, 4th. The company reported $0.85 EPS for the quarter, topping analysts' consensus estimates of $0.78 by $0.07. The business earned $125.90 million during the quarter, compared to the consensus estimate of $124.67 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 11.29% and a net margin of 5.81%. U.S. Physical Therapy's quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.86 EPS.

U.S. Physical Therapy declared a quarterly dividend on Thursday, February 23rd. Investors of record on Friday, March 10th will be given a dividend of $0.43 per share on Friday, April 7th. This represents a $1.72 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend is Thursday, March 9th. This is a boost from the stock's previous quarterly dividend of $0.41.
Read our dividend analysis for USPH.

ETFs with the largest weight of U.S. Physical Therapy (NYSE:USPH) stock in their portfolio include Emerge EMPWR Sustainable Select Growth Equity ETF (EMGC), Small Cap US Equity Select ETF (RNSC), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Emerge EMPWR Unified Sustainable Equity ETF (EMPW), VictoryShares US Small Cap High Div Volatility Wtd ETF (CSB), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD) and Royce Quant Small-Cap Quality Value ETF (SQLV).

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.72 per share and currently has a dividend yield of 1.80%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 76.44%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 54.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (7.04%), Morgan Stanley (5.40%), Copeland Capital Management LLC (4.64%), Boston Trust Walden Corp (4.07%), Riverbridge Partners LLC (3.09%) and Dimensional Fund Advisors LP (2.80%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Carey P Hendrickson, Christopher J Reading, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Richard Binstein.
View institutional ownership trends.

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USPH stock can currently be purchased for approximately $91.95.

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.20 billion and generates $553.14 million in revenue each year. The company earns $32.16 million in net income (profit) each year or $2.25 on an earnings per share basis.

The company employs 6,135 workers across the globe.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.